{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:38:01Z","timestamp":1790635081121,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,10,30]],"date-time":"2002-10-30T00:00:00Z","timestamp":1035936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The 42\u2010amino\u2013acid isoform of \u03b2\u2010amyloid A\u03b242 in the cerebrospinal fluid (CSF) has recently been proposed as a biochemical marker for Alzheimer's disease (AD) and subcortical white\u2010matter dementia (SWD). In both of these conditions, concentration of CSF\u2010A\u03b242 is reduced. We quantified CSF\u2010A\u03b242 from patients fulfilling strict clinical criteria for multiple system atrophy (MSA; n = 36), Parkinson's disease (PD; n = 48) and progressive supranuclear palsy (PSP; n = 15). The study groups were consecutively recruited among patients referred to a movement disorder unit, and 32 healthy, age\u2010matched volunteers were used as controls. The CSF concentration of A\u03b242 was significantly reduced in the MSA group (<jats:italic>P<\/jats:italic> &lt; 0.001), whereas the PD and PSP groups did not differ from controls. On an individual basis, low content of A\u03b242 was seen in 9 MSA patients regardless of age and disease duration. Three PD patients with long disease duration also had low concentrations but all PSP patients were normal. We conclude that the reduced CSF\u2010A\u03b242 concentration may be a clue to the pathogenesis of MSA. There is a decreased production, or more possible, an increased consumption of CSF\u2010A\u03b242. The analysis of this protein may also become a supplement to the clinical differentiation of parkinsonian syndromes in a movement disorder unit.<\/jats:p>","DOI":"10.1002\/mds.10321","type":"journal-article","created":{"date-parts":[[2003,1,22]],"date-time":"2003-01-22T17:16:26Z","timestamp":1043255786000},"page":"186-190","source":"Crossref","is-referenced-by-count":89,"title":["Cerebrospinal fluid A\u03b242 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy"],"prefix":"10.1002","volume":"18","author":[{"given":"Bj\u00f6rn","family":"Holmberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Johnels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,10,30]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"321","volume-title":"Autonomic failure: a textbook of the autonomic nervous system","author":"Daniel SE","year":"1999"},{"key":"e_1_2_6_3_2","first-page":"145","volume-title":"Parkinson's disease and movement disorders","author":"Golbe L","year":"1993"},{"key":"e_1_2_6_4_2","first-page":"1","article-title":"Overview of morphological changes in Parkinson's disease","volume":"45","author":"Jellinger K","year":"1987","journal-title":"Adv Neurol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/117.2.235"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130116"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(00)00083-3"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.67052013.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.5.1090"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.2740"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-9781(02)00056-6"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-1999-1606"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.5.1099"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.8.1555"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007020070079"},{"key":"e_1_2_6_16_2","first-page":"189","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"74","author":"Gilman S","year":"1998","journal-title":"J Auton Nerv Syst"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.3.181"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.1.1"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.52.Suppl.78"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.427"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/13506120009146438"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(94)90011-6"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02815140"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/325733a0"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)01537-8"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007020050002"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1999.tb00553.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050918"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.1.102"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703063361004"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1062"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf080"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.10321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:59:39Z","timestamp":1760961579000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.10321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,30]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1002\/mds.10321"],"URL":"https:\/\/doi.org\/10.1002\/mds.10321","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10,30]]}}}